Bumper Offer - Urjas oil Just @ Rs. 1
Tsart 20 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Heart Failure, High BP. Secondary and off-label uses of Tsart 20 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Tsart 20 Tablet. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Tsart 20 Tablet include Dizziness, Nausea or vomiting, Back Pain. While these are the most often observed Tsart 20 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Tsart 20 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Tsart 20 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. It is important to know if Tsart 20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Tsart 20 Tablet related warnings section.
Tsart 20 Tablet is contraindicated in people with pre-existing medical conditions like Angioedema, Hyperkalemia, Drug Allergy as it can result in adverse effects.
Drug interactions for Tsart 20 Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Tsart 20 Tablet is considered not safe while driving, and is not addictive.
Tsart 20 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tsart 20 Tablet is used -
Severe
Mild
Common
Is the use of Tsart 20 Tablet safe for pregnant women?
Tsart should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Tsart 20 Tablet safe during breastfeeding?
Tsart has been seen to have minimal side effects on breastfeeding women.
What is the effect of Tsart 20 Tablet on the Kidneys?
Tsart is not harmful for kidneys.
What is the effect of Tsart 20 Tablet on the Liver?
Tsart is rarely harmful for the liver.
What is the effect of Tsart 20 Tablet on the Heart?
Side effects of Tsart rarely affect the heart.
Tsart 20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tsart 20 Tablet unless your doctor advises you to do so -
Is this Tsart 20 Tablet habit forming or addictive?
Forming a habit of Tsart 20 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tsart 20 Tablet, you should not drive or work on any heavy machine, as Tsart 20 Tablet can make you drowsy.
Is it safe?
Tsart 20 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Tsart 20 Tablet in mental disorders is not effective.
Interaction between Food and Tsart 20 Tablet
When consumed with certain foods, Tsart 20 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tsart 20 Tablet
Taking alcohol with Tsart 20 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
